We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
+93.46%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
AUM
$79.6M
AUM Growth
+$38.5M
Cap. Flow
-$35
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CTEV
Claritev Corp
CTEV
+$35

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTEV
1
Claritev Corp
CTEV
$652M
$79.6M 100%
5,387,858
-4
-0% -$35

Similar funds

H&F Corporate Investors VIII's Q4 2024 Portfolio in Review

As of Q4 2024, H&F Corporate Investors VIII held 1 position worth $79.6M, up 93% from $41.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VIII's biggest Q4 2024 reduction was Claritev Corp, cutting an estimated $35.
  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $79.6M portfolio in Q4 2024.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q4 2024.
  • H&F Corporate Investors VIII's portfolio value rose 93% quarter-over-quarter to $79.6M.

Based on H&F Corporate Investors VIII's 13F filing for Q4 2024, filed 12 Feb 2025.